Transcriptomic Validation

Transcriptomic Validation is a methodological framework in cancer immunogenomics that confirms the expression of predicted neoantigens by analyzing RNA-sequencing data to distinguish transcriptionally active mutations from silent or non-expressed variants.

189

Publications

10.7K

Citations

1.7K

Authors

676

Institutions

Publications per year

2017–2026

135

Authors

1.7K

  1. PC
    Pablo Canales-Herrerías

    Inserm, France

    2 publications · 52 citations

    2

    h-index

  2. SD
    Shengming Dai

    Fourth Affiliated Hospital of Guangxi Medical University, China

    2 publications · 126 citations

    2

    h-index

  3. CA
    Carmen Argmann

    Icahn School of Medicine at Mount Sinai, United States

    2 publications · 52 citations

    2

    h-index

  4. JY
    Jane Yu

    Brigham and Women's Hospital, United States

    2 publications · 131 citations

    2

    h-index

  5. GC
    Grace Chung

    Icahn School of Medicine at Mount Sinai, United States

    2 publications · 52 citations

    2

    h-index

1–5 of 1.7K

Venues

  1. Scientific Reports

    8 publications · 314 citations

    9

    h-index

  2. PLoS ONE

    8 publications · 331 citations

    8

    h-index

  3. BMC Cancer

    7 publications · 456 citations

    7

    h-index

  4. Frontiers in Immunology

    6 publications · 129 citations

    6

    h-index

  5. Oncotarget

    5 publications · 1.2K citations

    5

    h-index

1–5